Enzyme immunoassay for factor VIII-related antigen.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Clinical Chemistry

• Publication date

  1982-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CLINCHEM/28.6.1356PMID 6804126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carrier Detection in Haemophilia A by Immunological Measurement of Factor VIII Related Antigen (VIIIRAg) and Factor VIII Clotting Antigen (VIIICAg)

  1981cited by this paper
• A Simple Enzyme-Immunoassay (EIA) Test for Factor VIII-Related Antigen (VIIIAGN)

  1979cited by this paper
• Report of the Working Party on Factor VIII-Related Antigens

  1978cited by this paper
• The use of an immunoradiometric assay for factor VIII related antigen in the study of atypical Von Willebrand's disease.

  1977cited by this paper
• A co-operative study for the detection of the carrier state of classic hemophilia.

  1977cited by this paper
• The laboratory diagnosis of the carrier state for classic hemophilia.

  1977cited by this paper
• Von Willebrand's disease: combined qualitative and quantitative abnormalities.

  1977cited by this paper
• Factor-VIII-related antigen: measurement by enzyme immunoassay.

  1976cited by this paper
• Immunoradiometric Assay of Factor VIII Related Antigen, with Observations in 32 Patients with von Willebrand's Disease

  1976cited by this paper
• Determination of the von Willebrand's disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis.

  1975cited by this paper
• Radioimmunoassay of antihaemophilic factor (factor VIII) antigen.

  1975cited by this paper
• Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor 8().

  1971cited by this paper
• Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

  1971cited by this paper
• Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

  1966cited by this paper

• Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019

  2023cites this paper
• Elevated Serum Cystatin C and Decreased Cathepsin S/Cystatin C Ratio Are Associated with Severe Peripheral Arterial Disease and Polyvascular Involvement

  2022cites this paper
• Structural hierarchy of mechanical extensibility in human von Willebrand factor multimers

  2022cites this paper
• Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients

  2022cites this paper
• von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019

  2021cites this paper
• Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock

  2020cites this paper
• Leptin levels are not affected by enalapril treatment after an uncomplicated myocardial infarction, but associate strongly with changes in fibrinolytic variables in men

  2020cites this paper
• How we make an accurate diagnosis of von Willebrand disease.

  2020cites this paper
• COVID-19 is associated with relative ADAMTS13 deficiency and VWF multimer formation resembling TTP

  2020cites this paper
• ADAMTS13 activity is associated with early neurological improvement in acute ischemic stroke patients treated with intravenous thrombolysis

  2019cites this paper
• ADAMTS-13 Activity Predicts Outcome in Acute Ischaemic Stroke Patients Undergoing Endovascular Treatment

  2018cites this paper
• Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study

  2018cites this paper
• Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation

  2018cites this paper
• Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.

  2017cites this paper
• Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.

  2017cites this paper
• Developments in the diagnostic procedures for von Willebrand disease

  2016cites this paper
• Carboxiterminal pro-endothelin-1 as an endothelial cell biomarker in thrombotic thrombocytopenic purpura

  2016influential citation
• High circulating osteoprotegerin levels are associated with non-zero blood groups

  2016cites this paper
• Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease

  2016cites this paper
• Prospective evaluation of ADAMTS-13 and von Willebrand factor multimers in cardiac surgery

  2016cites this paper
• Arterial spin labeling perfusion MRI: Inter-vendor reproducibility and clinical applicability

  2015cites this paper
• Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement.

  2015cites this paper
• Primary Biliary Cirrhosis An epidemiological and clinical study based on patients from Northern Sweden by PER UDDENFELDT

  2014cites this paper
• The Long-Term Effects of Pitavastatin on Blood Lipids and Platelet Activation Markers in Stroke Patients: Impact of the Homocysteine Level

  2014cites this paper
• Correlation between endogenous VWF:Ag and PK parameters and bleeding frequency in severe haemophilia A subjects during three-times-weekly prophylaxis with rFVIII-FS

  2013cites this paper
• Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease.

  2013cites this paper
• Nonsense mediated decay of VWF mRNA subsequent to c.7674-7675insC mutation in type3 VWD patients.

  2012cites this paper
• Laboratory Diagnosis of von Willebrand Disease: The Phenotype

  2011cites this paper
• multimer distribution in plasma Elevated platelet count as a cause of abnormal von Willebrand factor

  2011cites this paper
• Laboratory predictors of dengue shock syndrome during the febrile stage.

  2010cites this paper
• Fibrinolysis and von Willebrand factor in Alzheimer's disease and vascular dementia--a case-referent study.

  2010cites this paper
• ADIPOCYTE-DERIVED HORMONES AND CARDIOVASCULAR DISEASE

  2010cites this paper
• Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.

  2010cites this paper
• Von-Willebrand-Faktor-und ADAMTS13-Diagnostik

  2010cites this paper
• Effects of Atenolol or Losartan on Fibrinolysis and von Willebrand Factor in Hypertensive Patients With Left Ventricular Hypertrophy

  2010cites this paper
• Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.

  2010cites this paper
• Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years

  2009cites this paper
• Structure-function relationships of von Willebrand factor

  2009cites this paper
• ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

  2009cites this paper
• Laboratory Diagnosis and Molecular Basis of Mild von Willebrand Disease Type 1

  2009cites this paper
• Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells.

  2009cites this paper
• Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure

  2009cites this paper
• Novel evaluation method for densitometric curves of von Willebrand Factor multimers and a new parameter (MMW) to describe the degree of multimersation

  2009cites this paper
• Plasma markers of coagulation and endothelial activation in Fabry disease: impact of renal impairment.

  2009cites this paper
• Rolle der von Willebrand-Faktor-spaltenden-Protease ADAMTS-13 bei Patienten mit systemischer Inflammation

  2008cites this paper
• PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2

  2008cites this paper
• UvA-DARE ( Digital Academic Repository ) Cell-derived microparticles : composition and function

  2008cites this paper
• The influence of acute-phase levels of haemostatic factors on reperfusion and mortality in patients with acute myocardial infarction treated with streptokinase

  2008cites this paper
• Pediatric REFERENCE Values for Molecular Markers in Hemostasis

  2007cites this paper
• Classification and Characterization of Hereditary Types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (Unclassifiable) von Willebrand Disease

  2006cites this paper
• Characterization of Recessive Severe Type 1 and 3 von Willebrand Disease (VWD), Asymptomatic Heterozygous Carriers Versus Bloodgroup O-Related von Willebrand Factor Deficiency, and Dominant Type 1 VWD

  2006cites this paper
• Muscle fiber type I influences lipid oxidation during low‐intensity exercise in moderately active middle‐aged men

  2006influential citation
• ST-elevation myocardial infarction : studies of outcome in relation to fibrinolysis and ischemia monitoring with on-line vectorcardiography.

  2006cites this paper
• Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection

  2005cites this paper
• Risk markers for a first myocardial infarction

  2005cites this paper
• Comparison of soluble thrombomodulin, von Willebrand factor, tPA/PAI-1 complex, and high-sensitivity CRP concentrations in serum, EDTA plasma, citrated plasma, and acidified citrated plasma (Stabilyte) stored at -70 degrees C for 8-11 years.

  2005cites this paper
• IGM-containing immune complexes and antiphospholipid antibodies in patients with Sneddon's syndrome

  2004cites this paper
• Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction

  2004cites this paper
• Clinical Chemistry through Clinical Chemistry: A Journal Timeline

  2004cites this paper
• Hemostatic Factors as Risk Markers for Intracerebral Hemorrhage: A Prospective Incident Case-Referent Study

  2004cites this paper
• Applicationof Enzyme Immunoassaysto CoagulationTesting

  2004cites this paper
• Endothelial injury and altered hemodynamics in thalassemia

  2004cites this paper
• Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII–von Willebrand factor concentrate (Haemate-P)

  2004cites this paper
• Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment.

  2003cites this paper
• Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women

  2003cites this paper
• Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head

  2003cites this paper
• Improved Fibrinolysis after one Year of Treatment with Enalapril in Men and Women with Uncomplicated Myocardial Infarction

  2002cites this paper
• Mitochondrial DNA depletion in Leigh syndrome.

  2002cites this paper
• Functional characterization of a natural variant of luteinizing hormone

  2002cites this paper
• Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.

  2002cites this paper
• Laboratory diagnosis of congenital von Willebrand disease.

  2002cites this paper
• Prospective Study on Soluble Thrombomodulin and von Willebrand Factor and the Risk of Ischemic and Hemorrhagic Stroke

  2002cites this paper
• Quantitative Measurement of Carotid Atherosclerosis in Relation to Levels of Von Willebrand Factor and Fibrinolytic Variables in Plasma — A 2-year Follow-Up Study

  2002cites this paper
• Response of von Willebrand Factor Parameters to Desmopressin in Patients with Type 1 and Type 2 Congenital von Willebrand Disease: Diagnostic and Therapeutic Implications

  2002cites this paper
• Laboratory Diagnosis of Congenital von Willebrand Disease

  2002cites this paper
• Tissue factor pathway inhibitor does not influence inflammatory pathways during human

  2001cites this paper
• Von Willebrand factor and von Willebrand disease.

  2001cites this paper
• Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data

  2001influential citation
• Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment.

  2001cites this paper
• Fibrinolytic actions of intra-arterial angiotensin II and bradykinin in vivo in man.

  2000cites this paper
• Effects of alcohol and the evening meal on shear-induced platelet aggregation and urinary excretion of prostanoids.

  2000cites this paper
• Type 1 von Willebrand disease — a clinical retrospective study of the diagnosis, the influence of the ABO blood group and the role of the bleeding history

  2000cites this paper
• ACE‐inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients

  2000cites this paper
• Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women.

  1999cites this paper
• Anti-Kaposi’s Sarcoma and Antiangiogenic Activities of Sulfated Dextrins

  1999cites this paper
• Phospholipid binding of factor VIII in different therapeutic concentrates

  1999cites this paper
• Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke.

  1999cites this paper
• Effect of Cold Exposure, Exercise and High Altitude on Plasma Endothelin-1 and Endothelial Cell Markers in Man

  1999cites this paper
• Identification of the Binding Site for an Alloantibody to von Willebrand Factor which Inhibits Binding to Glycoprotein Ib within the Amino-terminal Region Flanking the A1 Domain

  1999cites this paper
• Grandpaternal mosaicism in a family with isolated haemophilia A

  1999cites this paper
• 1-Deamino (8-D-arginine) vasopressin infusion partially corrects platelet deposition on subendothelium in Bernard-Soulier syndrome: the role of factor VIII.

  1999cites this paper
• Variations in Coagulation Factors in Women: Effects of Age, Ethnicity, Menstrual Cycle and Combined Oral Contraceptive

  1999cites this paper
• Acquired von Willebrand Disease in Monoclonal Gammapathies: Effectiveness of High-dose Intravenous Gamma Globulin

  1999cites this paper
• Frequency of inherited bleeding disorders in women with menorrhagia.

  1998cites this paper
• Distinct Associations of HbA1c and the Urinary Excretion of Pentosidine, an Advanced Glycosylation End-product, with Markers of Endothelial Function in Insulin-dependent Diabetes mellitus

  1998influential citation
• Cartilage reconstruction in head and neck surgery: comparison of resorbable polymer scaffolds for tissue engineering of human septal cartilage.

  1998cites this paper
• The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man.

  1998cites this paper
• Impaired Haemostasis by Intravenous Administration of a Gelatin-based Plasma Expander in Human Subjects

  1998influential citation
• Effect of octreotide on the pathology of hepatic schistosomiasis.

  1998cites this paper
• Size-exclusion chromatography of plasma proteins with high molecular masses.

  1998cites this paper